Anondita Medicare Ltd vs Infollion Research Services Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 23, 2026

Key Highlights

The Latest Trading Price of Anondita Medicare Ltd is ₹ 657 as of 23 Mar 15:30 . The P/E Ratio of Anondita Medicare Ltd is 0 as of March 2024 .The P/E Ratio of Infollion Research Services Ltd is 21.7 as of March 2024 . The Market Cap of Anondita Medicare Ltd is ₹ 0 crore as of March 2024 .The Market Cap of Infollion Research Services Ltd is ₹ 185.53 crore as of March 2024 . The Dividend Payout of Anondita Medicare Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Infollion Research Services Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Anondita Medicare Ltd

Anondita Medicare Limited was incorporated as a Public Limited Company on March 12, 2024, with the Registrar of Companies, Central Registration Centre.
Prior to this, Company business was run by current promoter, Mr. Anupam Ghosh, as a sole proprietorship under the name of M/s Anondita Healthcare (formerly M/s Healthcare Products) from year 1999 onwards. Company is a manufacturer of male condoms with a variety of flavors, with our flagship product marketed and sold under the brand 'COBRA'.
It operate an installed production capacity of nearly 562 million condoms per annum, as per certificate issued by JP Sood, Chartered Engineer, dated November 21, 2024.
Further, to follow sustainable production practices, Company uses CNG as a clean, environmentally friendly manufacturing fuel for its manufacturing plant situated at Sector 80, Gautam Budh Nagar, Noida, Uttar Pradesh.

About Infollion Research Services Ltd

Infollion Research Services Limited was formerly incorporated as a Private Company in the name of ' Infollion Research Services Private Limited' dated September 09, 2009, issued by the RoC, Delhi & Haryana.
The Company converted into a Public Company and name of the Company was changed to 'Infollion Research Services Limited' vide a fresh Certificate of Incorporation issued by the RoC, Delhi on October 12, 2022. The Company is a tech-oriented marketplace, operating in the B2B Human Cloud segment, catering to on-demand contingent hiring and work arrangements with senior management talent, subject matter experts, independent consultants and high-ranking, seasoned professionals.
The Company provide a platform for workers or knowledge providers (gig workers) and employers or knowledge seekers to connect and find synergistic outcomes.

FAQs for the comparison of Anondita Medicare Ltd and Infollion Research Services Ltd

Which company has a larger market capitalization, Anondita Medicare Ltd or Infollion Research Services Ltd?

Market cap of Anondita Medicare Ltd is 1,188 Cr while Market cap of Infollion Research Services Ltd is 274 Cr

What are the key factors driving the stock performance of Anondita Medicare Ltd and Infollion Research Services Ltd?

The stock performance of Anondita Medicare Ltd and Infollion Research Services Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Anondita Medicare Ltd and Infollion Research Services Ltd?

As of March 23, 2026, the Anondita Medicare Ltd stock price is INR ₹657.0. On the other hand, Infollion Research Services Ltd stock price is INR ₹283.0.

How do dividend payouts of Anondita Medicare Ltd and Infollion Research Services Ltd compare?

To compare the dividend payouts of Anondita Medicare Ltd and Infollion Research Services Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.